https://api.elsevier.com/content/article/pii/S1551714421000823doi:10.1016/j.cct.2021.1063461-s2.0-S155171442100082310.1016/j.cct.2021.106346S1551-7144(21)00082-3Continuous infusion versus intermittent administration of meropenem in critically ill patients (MERCY): A multicenter randomized double-blind trial. Rationale and design Contemporary Clinical TrialsJournal155171442021-05-31May 20210falsefalse